AUGUSTA, Ga., July 11, 2012 /PRNewswire/ -- inVentiv Medical Management (iMM), an inVentiv Health company and provider of best-in-class medical management services to the healthcare industry, today announced that it has formed a partnership with Vital Decisions to better serve the needs of payers, providers, and seriously ill patients nationwide. The joint offering will support patients by empowering them to be more proactive decision makers when it comes to their health, and, thereby, reduce the use of costly care that is medically inappropriate or unwanted by individuals with advanced illnesses.
Together, iMM and Vital Decisions – an Edison, New Jersey-based company that provides patient-centered behavioral counseling programs for those with advanced illnesses – will offer a unique care management and counseling program to individuals battling metastatic cancer, end-stage heart or lung disease, and progressive neurologic conditions, such as Alzheimer's or Lou Gehrig's disease (Amyotrophic Lateral Sclerosis-ALS). The program is designed to encourage patients to work with their physicians and family members to make well-informed care decisions as their illnesses progress. inVentiv Medical Management case managers will provide patients with clinical advice, while Vital Decisions specialists will offer counseling support using the company's proprietary "Living Well" program, which helps individuals with advanced illnesses communicate their quality-of-life preferences to those involved in their care.
"As their diseases progress, many patients with advanced illnesses receive care that they do not necessarily want or is medically inappropriate," said Marc Palmer, CEO, iMM. "Vital Decisions' commitment to patient needs and its care management goals so closely mirror our own. We believe that together we can empower patients to become more active decision makers when it comes to their health, help them get appropriate care and avoid much of the unnecessary physical and emotional pain associated with advanced illnesses."
Mitchell Daitz, CEO, Vital Decisions, said: "Through this partnership, we expect to bring additional support to a population that has previously experienced significant value from inVentiv Medical Management's Accountable Care Solutions and other clinical support services. We are committed to improving outcomes by proactively engaging with seriously ill patients and educating them about the options available to them."
About Vital Decisions
Vital Decisions is the leader in providing health care counseling services to individuals and their families who are facing an advanced illness. Their proprietary counseling methodology, called the Living Well Program, enables patients to become more active participants in identifying, communicating and incorporating their individual preferences and priorities into current and future decisions about their care. For more information, visit http://www.vitaldecisions.net.
About Accountable Care Solutions Powered by inVentiv Medical Management™
Accountable Care Solutions Powered by inVentiv Medical Management, provides customers with a dedicated staff of specialty care physicians, nurses and billing experts who use evidence-based standards to evaluate and enhance the delivery of medical care to patients with some of the most complex and costly health conditions. inVentiv's suite of Accountable Care Solutions includes Comprehensive Oncology Care Management, Comprehensive Cardiovascular Care Management and Comprehensive Kidney Care Management.
About inVentiv Medical Management
inVentiv Medical Management, an inVentiv Health company, is a leading national provider of physician-directed, nurse-supported, technology-enabled, medical management solutions to third party administrators, self-funded or fully insured plans, employer groups, managing general underwriters and insurance carriers. With a mission of improving healthcare costs, quality and outcomes, we deliver balanced clinical surveillance and cost intervention that supports payers, providers and patients. inVentiv Medical Management is headquartered in Augusta, Georgia. Please visit http://www.inventivmm.com for more information.
About inVentiv Health
inVentiv Health, Inc. is a leading global provider of best-in-class clinical, commercial and consulting services to companies seeking to accelerate performance. inVentiv's client roster includes more than 550 pharmaceutical, biotech and life sciences companies. With 13,000 employees in 40 countries, inVentiv rapidly transforms promising ideas into commercial reality. inVentiv Health Inc. is privately owned by inVentiv Group Holdings Inc., an organization sponsored by affiliates of Thomas H. Lee Partners, L.P., Liberty Lane Partners and members of the inVentiv management team. For more information, visit http://www.inventivhealth.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause our performance to differ materially. These forward-looking statements reflect our current views about future events and are subject to risks, uncertainties and assumptions. We wish to caution readers that certain important factors may have affected and could in the future affect our actual results and could cause actual results to differ significantly from those expressed in any forward-looking statement. Such factors include, without limitation: the impact of our substantial level of indebtedness on our ability to generate sufficient cash to fulfill our obligations under our existing debt instruments or our ability to incur additional indebtedness; the impact of the consummation of any announced and future acquisitions; the impact of any additional leverage we may incur in connection with the financing of acquisitions, on our ratings and the ratings of our debt securities; our ability to sufficiently increase our revenues and maintain or decrease expenses and cash capital expenditures to permit us to fund our operations; our ability to continue to comply with the covenants and terms of our senior secured credit facilities and to access sufficient capital under our credit agreement or from other sources of debt or equity financing to fund our operations; the impact of any default by any of our credit providers; our ability to accurately forecast costs to be incurred in providing services under fixed price contracts; our ability to accurately forecast insurance claims within our self- insured programs; the potential impact of pricing pressures on pharmaceutical manufacturers from future healthcare reform initiatives or from changes in the reimbursement policies of third-party payers; our ability to grow our existing client relationships, obtain new clients and cross-sell our services; the potential impact of financial, economic, political and other risks, including interest rate and exchange rate risks, related to conducting business internationally; our ability to successfully operate new lines of business; our ability to manage our infrastructure and resources to support our growth; our ability to successfully identify new businesses to acquire, conclude acquisition negotiations and integrate the acquired businesses into our operation, and the resulting synergies; the resolution of purchase price adjustment disputes in connection with our recent acquisitions and related impacts; any disruptions, impairments, or malfunctions affecting software as well as excessive costs or delays that may adversely impact our continued investment in and development of software; the potential impact of government regulation on us and on our client base; our ability to comply with all applicable laws as well as our ability to successfully implement from a timing and cost perspective any changes in applicable laws; our ability to recruit, motivate and retain qualified personnel, including sales representatives; the possibility that client agreements will be terminated or not renewed; any potential impairment of goodwill or intangible assets; consolidation in the pharmaceutical industry; changes in trends in the healthcare and pharmaceutical industries or in pharmaceutical outsourcing, including initiatives by our clients to perform services we offer internally; the impact of customer project delays and cancellations; our ability to convert backlog into revenue; the potential liability associated with bringing new drugs to market, including potential liability from injury to clinical trial participants; the actual impact of the adoption of certain accounting standards; and our ability to maintain technological advantages in a variety of functional areas, including sales force automation, electronic claims surveillance and patient compliance. Holders of our debt instruments are referred to reports provided to investors from time to time and the offering memorandums provided in connection with the issuance of our senior secured notes for further discussion of these risks and other factors.
SOURCE inVentiv Medical Management